Passage odds have fallen to a coin flip, the July 4 deadline is gone, and Senator Lummis has named the price of failure: a wait until 2030. Here are the three ways this ends, what each one is worth, and how to tell which is unfolding.
Summary
- The CLARITY Act is no longer a simple pass-or-fail trade.
- Delay into 2027 is the quiet risk the market is least prepared for.
- Passage would matter most for assets with unresolved classification risk.
- Failure would keep US crypto regulation dependent on agency interpretation for years.
For most of this year the CLARITY Act felt like a question of when, not whether. It passed the House 294 to 134, cleared the Senate Banking Committee 15 to 9 on May 14, landed on the Senate calendar on June 1, and carried prediction-market odds above 70%. The most consequential piece of crypto legislation in American history looked close enough that the industry started pricing the win.
The mood has turned. The White House targeted a July 4 signing, and that deadline is now, in the words of one Fox Business correspondent tracking the bill closely, logistically dead, because the bill still needs a full Senate vote, House reconciliation, and a presidential signature, none of which can be compressed into the time remaining.
Two negotiations have fractured at once, an ethics fight over the President’s crypto holdings and a law-enforcement fight over developer protections in Section 604. Prediction markets that priced passage near 75% in May now hover between 45% and 59% depending on the platform and the day.
Senator Cynthia Lummis, one of the bill’s chief architects, has put a number on what failure costs: a wait until 2030, because a new Congress would have to restart the entire process from scratch.
That shift turns a victory lap into a real fork, and the clearest way to think about a fork is in scenarios. This piece lays out the three realistic paths from here: passage before the August recess, delay into 2027, and outright failure to 2030, with a rough probability on each and a clear-eyed read on what each would mean for the major assets, institutional capital, and the broader market.
The goal is not to predict which happens. It is to give you the framework to recognize which one is unfolding as the next six weeks play out, and to understand what is at stake in each.
Where the bill actually stands
The scenarios only make sense against an accurate baseline, so start with the current state.
The CLARITY Act has completed five of nine steps toward becoming law. It passed the House in 2025, cleared the Senate Banking Committee in May 2026, and secured a place on the Senate Legislative Calendar on June 1.
Four steps remain: full Senate floor debate, a 60-vote passage threshold, House-Senate reconciliation to merge the chambers’ versions, and a presidential signature. Each of those four is a real obstacle, and the 60-vote threshold is the tallest, because it requires roughly seven Democrats beyond the two who crossed over in committee.
The two committee crossovers, Senators Ruben Gallego and Angela Alsobrooks, made their support explicitly conditional on further work, and the conditions have since split into the two fights that created this fork. The ethics fight turns on provisions restraining officials, the President’s family most of all, from crypto conflicts of interest, after the family generated an estimated $2.3 billion from crypto ventures.
The Section 604 fight turns on developer protections that law enforcement groups want narrowed and the crypto industry wants preserved, with Senators Mark Warner and Catherine Cortez Masto tying their votes to law enforcement’s sign-off. One stablecoin-related dispute was already settled through a Tillis-Alsobrooks deal, which proves the fights are winnable, but the two that remain are live and fractured at the same time.
Behind every scenario sits the hard constraint of the calendar. The Senate has on the order of 31 session days before the August recess, no floor date is scheduled, and the chamber is competing with surveillance reauthorization, budget work, and must-pass funding bills.
That is the board. Now the three ways the game ends.
Scenario one: passage before the recess
Probability: roughly 35% to 45%. This is the scenario the prediction markets and the research desks still treat as live, though no longer as the favorite.
For passage to happen before the recess, both poison pills have to be defused in a matter of weeks. The ethics fight would need a compromise that gives Democrats real enforcement teeth without the White House reading it as targeting the President, the precise circle that the collapsed Tuesday meeting failed to square.
The Section 604 fight would need the White House’s law-enforcement outreach to satisfy the sheriffs and prosecutors enough to release Warner and Cortez Masto, without stripping the developer protections that would cost the bill its industry support. Then the merged bill needs floor time the leadership has not yet scheduled, 60 votes, a House that accepts the reconciled text, and a signature.
It is a lot to do in six weeks, but it is not impossible. The bill has surprised skeptics before by finding last-minute deals, as the committee markup itself did.
If it passes, the outcome is the largest positive catalyst crypto has had from Washington. The framework that has been promised for years becomes statute: the SEC-CFTC jurisdiction split is settled, digital-commodity classification is written into law instead of agency interpretation, and the developer protections and market-structure rules give institutions the durable certainty they have been waiting for.
The assets with the most classification overhang re-rate first and hardest, because they have the most uncertainty to shed. XRP is the clearest beneficiary, since the statute would make permanent the commodity classification the SEC and CFTC granted by interpretation in March, the difference between a ruling the next administration can reverse and a law it cannot.
That is what the bill would unlock for the most exposed asset. Standard Chartered’s conditional $8 XRP target is built on exactly this scenario plus sustained ETF inflows.
Ethereum carries real exposure too, with one bank holding a $7,500 conditional 2026 target tied to passage. The broad market would likely read passage as the all-clear that unlocks the next wave of institutional allocation.
One catch worth remembering: much of this is already partly priced. The market spent the spring expecting passage, so a yes vote delivers the catalyst but with some of the move already pulled forward.
The cleanest gains would accrue to the specific assets whose classification the statute resolves, not to the market as a whole.
Scenario two: delay into 2027
Probability: roughly 35% to 45%. This has quietly become the most likely single outcome, and it is the one the market is least prepared for, because it is neither the win nor the catastrophe.
Delay happens when the bill does not fail outright but runs out of runway. The poison pills prove too tangled to defuse before the recess, leadership cannot find floor time amid competing priorities, the 60 votes do not materialize in the window, and the bill slips past August.
Lummis has warned that missing the pre-recess window risks pushing the bill into the political uncertainty of the midterm season, which is the mechanism that turns a short delay into a long one. A bill that does not pass before the recess does not automatically die, but it enters a far more hostile environment.
That environment includes a Senate distracted by elections, a narrowing willingness among Democrats to hand the administration a win, and a calendar that gets worse, not better, through the back half of the year.
Delay’s market consequence is a slow bleed of the premium that passage optimism built into prices, not a crash. The assets that rallied on passage hopes, XRP most visibly, give back the conditional premium as the timeline extends, and the conditional price targets get pushed out a year or revised down.
Standard Chartered already cut its near-term XRP target earlier in 2026 citing slow negotiations. Institutional capital that was waiting for statutory certainty keeps waiting, which means the larger allocation wave that passage would unlock simply does not arrive on the expected schedule.
Delay is not failure: the agency-level classifications from March stay in place, the ETFs keep trading, and the framework remains alive for a 2027 vote. But the market would spend the second half of 2026 trading without the catalyst it spent the first half anticipating, and that absence is itself a drag.
Delay is the scenario the market handles worst because it resists a clean narrative. Passage is a clear buy, failure is a clear sell, and delay is a grinding uncertainty that pulls support without offering resolution, the hardest condition to position around.
Scenario three: failure to 2030
Probability: roughly 15% to 25%. The least likely of the three, but no longer a tail risk, and the one with the largest consequences, which is why it deserves serious treatment instead of dismissal.
Outright failure means the bill does not pass in 2026 and does not get a realistic second chance until a new Congress rebuilds it from scratch. Lummis has named 2030 as the practical horizon for that reset, because a fresh Congress would have to restart the entire legislative process, reintroduce, re-markup, and re-negotiate in a political environment nobody can forecast.
Failure does not require a dramatic floor defeat. It requires only that the two poison pills stay unresolved through the recess and that the post-midterm Congress lacks the will or the composition to revive the bill.
A quiet death by calendar is more likely than a loud death by vote.
Failure’s consequences compound across the market. For the assets whose legal status the bill would settle, failure means living indefinitely with agency interpretation instead of statute, which is the reversible certainty that institutions discount.
XRP keeps its March commodity classification, but that classification stays vulnerable to a future administration, and the statutory permanence that underwrites the bull case never arrives. That would likely pull XRP back toward the bear-case range that assumes the disconnect persists, making it the asset with the most riding on the outcome.
The SEC-CFTC jurisdiction split stays unresolved, leaving the agencies to govern crypto by enforcement and interpretation, the very regime CLARITY was written to end. The developer protections of Section 604 do not become law, leaving open-source builders exposed to the money-transmitter question the bill would have settled.
ETF pipelines that depend on clear classification stall, and the institutional allocation wave that statutory certainty would unlock is deferred for years. The one bright spot is that the GENIUS Act’s stablecoin rules, already law, survive regardless, so the market is not left with nothing, just without the market-structure framework that matters most.
The deepest cost is not any single price move but the signal it sends. Even with House passage, committee approval, a supportive White House, and broad bipartisan agreement on the underlying goal, Congress could still fail to finish.
That would tell institutions that US crypto regulation remains a multi-year waiting game. It would also push the most cautious capital to keep sitting out or to deploy in friendlier jurisdictions.
That is the scenario the industry fears, and at 15% to 25%, it is real enough to plan around.
Why delay, not failure, is the underrated risk
Most coverage frames the question as pass-or-fail, which misreads the actual distribution, because the middle outcome is both the most likely and the most overlooked.
Binary framing exists because it makes a cleaner story. Either crypto gets its rulebook or it does not, either the catalyst fires or it dies.
But the calendar math points most strongly at neither extreme. The bill is too advanced and too widely supported to simply collapse, which caps the failure probability, and the poison pills are too tangled and the calendar too crowded to clear in six weeks with confidence, which caps the passage probability.
What is left in the middle, the bill surviving but not passing in the window and slipping toward an uncertain 2027, is the single fattest part of the probability distribution. It is also the outcome almost no one is positioning for.
This matters because delay and failure feel similar in the moment and resolve very differently. In both, the catalyst does not arrive on schedule and the passage premium bleeds out of prices.
But delay leaves the framework alive for a 2027 vote, while failure pushes it to 2030, and the difference between a one-year wait and a four-year reset is enormous for institutional planning and for the assets whose classification hangs in the balance. A market that lumps delay and failure together as the bear case will misprice both.
It will treat a survivable delay as a catastrophe and sell too hard, or it will dismiss the failure risk as merely delay and be unprepared if the bill truly dies. The two scenarios deserve separate handling, and the most likely path runs through the one the market is least equipped to read.
What to watch, scenario by scenario
The next six weeks will signal which path is unfolding, and a few specific markers separate the three.
A scheduled floor date is the clearest passage signal. Until leadership announces floor time, passage in the window stays aspirational, and the longer the calendar stays silent, the more probability shifts from passage toward delay.
A floor date being set, especially paired with news that one or both poison pills have a compromise, would be the strongest sign scenario one is live. That is why the full procedural map and calendar matters as much as the headline odds.
Watch also for a breakthrough on the ethics enforcement mechanism that both Democrats and the White House can accept, especially the conflict-of-interest fight in depth. The other signal is the White House’s law-enforcement outreach producing public sign-off from the police and prosecutor groups that would release Warner and Cortez Masto.
The delay signal is the absence of those things as the calendar burns. Each session day that passes without a floor date, without an ethics compromise, and without movement on Section 604 pushes probability from passage toward delay.
Any explicit acknowledgment from leadership that the bill will wait until after the recess would confirm scenario two. The failure signal is harder to spot because it arrives quietly: a recess that begins with the bill still stuck, followed by the post-midterm Congress showing no appetite to revive it, would mark the slide toward scenario three.
Lummis-style warnings about the 2030 horizon are the canary.
Above all, the prediction markets are the real-time gauge. They fell from above 70% to the high 40s and 50s as the poison pills hardened, and they will move first and fastest if either pill softens or if a floor date appears.
They are not infallible, but they aggregate the informed view better than any single headline. A sustained move back above 60% or down below 40% would tell you which scenario the smart money is converging on before the official outcome is known.
What it means for holders and traders
For holders of the assets most exposed to CLARITY, XRP above all, the practical reading is to size positions for a distribution of outcomes instead of a single bet. The bull case for these assets is real but conditional on passage, the bear case is real but conditional on failure, and the most likely path, delay, sits in between and pulls the conditional premium out without delivering the catastrophe.
A holder who has priced in passage as the base case is over-exposed to the most likely disappointment. A holder who has priced in failure is over-exposed to a deal that could still come together.
The disciplined position acknowledges all three branches and their rough weights.
For traders, the scenarios map to an event calendar with the floor date as the pivotal unknown. The passage premium can be traded on the markers above, building as a floor date and compromises appear, fading as the calendar burns silent.
The asymmetry to respect is that passage is partly priced while failure is not. That means the downside surprise of a confirmed delay or failure may move prices more than the upside surprise of a passage the market half-expects.
Between the markers, the CLARITY-exposed assets trade on the broad market and their own supply dynamics, as they have all year, with the legislative catalyst layered on top.
For institutions, the calculus is the cleanest, because it is the one the entire bill is about. The capital waiting on statutory certainty stays on the sidelines in both the delay and failure scenarios, and only passage releases it.
An institution modeling its crypto allocation around CLARITY should weight the roughly even odds of passage against the better-than-even combined odds of delay-or-failure. The most likely near-term outcome is continued waiting, not the green light.
The bill remains the single most important regulatory variable for US crypto. Its three-way fork is the dominant uncertainty for institutional capital through the back half of 2026.
The fork in the road
The CLARITY Act spent the first half of 2026 looking like a sure thing and enters its decisive stretch looking like a coin flip with a long tail. The three paths from here, passage in roughly four to five cases in ten, delay in another four to five, and failure to 2030 in perhaps two, define the most important regulatory question in US crypto.
They resolve over the next six weeks against a calendar that gives the coalition almost no room for error.
It is tempting to collapse this into hope or doom, to treat the bill as either the catalyst that lifts the market or the failure that sets it back years. The accurate picture is more uncomfortable: the single most likely outcome is the one in the middle, a delay that resolves nothing and pulls the passage premium out of prices while leaving the framework alive for a fight next year.
Passage would be the largest Washington catalyst crypto has had. Failure would push the rulebook to 2030 and tell institutions the wait is far from over.
Delay, the quiet favorite, would do neither. It would leave the market to spend the back half of the year trading without the catalyst it spent the front half expecting.
Watch the floor calendar, the two poison pills, and the prediction markets, in that order. They will tell you which fork the bill is taking before the headlines confirm it.
For a market that has waited a decade for a rulebook, the next six weeks decide whether the wait ends in 2026, extends to 2027, or stretches all the way to 2030. The odds, for now, are close enough that all three remain in play.
Frequently asked questions
What happens to crypto if the CLARITY Act fails?
If the bill fails outright, Senator Lummis has warned the next realistic chance for comprehensive crypto market-structure law is 2030, because a new Congress would have to restart the process. The practical consequences: the SEC-CFTC jurisdiction split stays unresolved, agencies keep governing crypto by enforcement and interpretation, XRP’s March commodity classification stays reversible rather than becoming permanent statute, Section 604 developer protections do not become law, and the institutional capital waiting on statutory certainty stays on the sidelines. The GENIUS Act’s stablecoin rules, already law, would survive regardless.
What are the odds the CLARITY Act passes in 2026?
Prediction markets price 2026 passage between roughly 45% and 59% as of mid-June, down from above 70% in May. Realistically the outcome splits three ways: passage before the August recess at roughly 35% to 45%, delay into 2027 at roughly 35% to 45%, and outright failure to around 2030 at roughly 15% to 25%. The July 4 signing target the White House wanted is no longer logistically possible.
Why is delay more likely than outright failure?
The bill is too advanced and too widely supported to simply collapse, which caps the failure probability. But the two unresolved fights, ethics and Section 604, are too tangled and the Senate calendar too crowded to clear with confidence in the six weeks before the recess. That leaves the middle outcome, the bill surviving but slipping past the window into an uncertain 2027, as the single most likely path. Most coverage still frames the question as a simple pass-or-fail.
Which crypto assets are most affected by the CLARITY Act?
XRP carries the most direct exposure, because the bill would convert its March 2026 commodity classification from a reversible agency interpretation into permanent statute, which underwrites bullish targets like Standard Chartered’s conditional $8. Ethereum has real exposure too, with conditional bank targets tied to passage. More broadly, any asset with classification uncertainty and the developer-dependent DeFi sector covered by Section 604 are exposed. Stablecoins are already covered by the separate GENIUS Act.
What is the difference between delay and failure for the CLARITY Act?
Delay means the bill misses the pre-recess window but stays alive for a 2027 vote, so the framework survives and the catalyst is merely postponed. Failure means the bill does not pass and does not get a realistic second chance until a new Congress rebuilds it, which Lummis has pegged at around 2030. The market often lumps the two together. A one-year delay and a four-year reset are very different for institutional planning and for the assets whose classification depends on the bill.
What should I watch to know which scenario is happening?
Three markers matter, in order. First, whether Senate leadership schedules a floor date, the clearest sign passage is live. Second, whether the two poison pills find compromises: an ethics enforcement mechanism both sides accept, and law-enforcement sign-off on Section 604 that releases the two Democratic holdouts. Third, the prediction markets, which move first and fastest: a sustained climb back above 60% signals passage, while a slide below 40% signals delay or failure.
As of June 16, 2026. Legislative status changes rapidly; verify the current state of negotiations before relying on this analysis. This article is information, not investment advice.